Upgrade to SI Premium - Free Trial

Cantor Fitzgerald Downgrades Celgene (CELG) to Neutral

October 27, 2017 7:36 AM
Cantor Fitzgerald downgraded Celgene (NASDAQ: CELG) from Overweight to Neutral with a price target of $112.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Downgrades

Next Articles